Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE: FMS · IEX Real-Time Price · USD
19.69
-0.28 (-1.40%)
At close: Jul 19, 2024, 4:00 PM
19.75
+0.06 (0.30%)
Pre-market: Jul 22, 2024, 7:02 AM EDT
FMS Revenue
Fresenius Medical Care AG & Co. KGaA had revenue of $21.17B in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $5.14B with 0.43% year-over-year growth. In the year 2023, Fresenius Medical Care AG & Co. KGaA had annual revenue of $21.62B with 4.74% growth.
Revenue (ttm)
$21.17B
Revenue Growth
-0.41%
P/S Ratio
0.55
Revenue / Employee
$176,622
Employees
119,845
Market Cap
11.55B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.62B | 978.94M | 4.74% |
Dec 31, 2022 | 20.64B | 614.96M | 3.07% |
Dec 31, 2021 | 20.02B | -1.76B | -8.07% |
Dec 31, 2020 | 21.78B | 2.14B | 10.91% |
Dec 31, 2019 | 19.64B | 617.18M | 3.25% |
Dec 31, 2018 | 19.02B | -2.32B | -10.88% |
Dec 31, 2017 | 21.34B | 3.90B | 22.38% |
Dec 31, 2016 | 17.44B | 652.24M | 3.89% |
Dec 31, 2015 | 16.79B | -3.71B | -18.10% |
Dec 31, 2014 | 20.50B | -1.00B | -4.66% |
Dec 31, 2013 | 21.50B | 2.02B | 10.37% |
Dec 31, 2012 | 19.48B | 2.07B | 11.87% |
Dec 31, 2011 | 17.41B | 467.96M | 2.76% |
Dec 31, 2010 | 16.94B | -312.31M | -1.81% |
Dec 31, 2009 | 17.26B | 1.43B | 9.05% |
Dec 31, 2008 | 15.82B | 621.99M | 4.09% |
Dec 31, 2007 | 15.20B | 3.24B | 27.05% |
Dec 31, 2006 | 11.97B | 3.40B | 39.76% |
Dec 31, 2005 | 8.56B | -474.60M | -5.25% |
Dec 31, 2004 | 9.04B | 1.59B | 21.32% |
Dec 31, 2003 | 7.45B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Universal Health Services | 14.66B |
DaVita | 12.34B |
Smith & Nephew | 5.55B |
Catalent | 4.14B |
Charles River Laboratories International | 4.11B |
Teleflex | 3.00B |
Royalty Pharma | 2.24B |
Bio-Techne | 1.15B |
FMS News
- 8 days ago - US FTC probing DaVita, Fresenius Medical, Politico reports - Reuters
- 5 weeks ago - Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations - PRNewsWire
- 2 months ago - Moody's and S&P change Fresenius Medical Care's rating outlook to stable - PRNewsWire
- 2 months ago - Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024 - PRNewsWire
- 2 months ago - Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets - PRNewsWire
- 2 months ago - Fresenius Medical sees up to 2% US dialysis growth by year-end - Reuters
- 2 months ago - Fresenius Medical Care starts the year with strong earnings growth - PRNewsWire
- 2 months ago - Fresenius Medical beats earnings expectations, keeps outlook; shares sink - Reuters